Strong Revenue Growth:
Hiring materials and company statements describe “explosive growth” and cite “500% year‑over‑year growth” since 2022, indicating rapid top‑line momentum. Industry coverage continues to list the company among active GLP‑1 telehealth brands in a fast‑growing category.
Market Expansion:
Announcements in 2025 detail enhanced national platform capabilities and the launch of in‑network plans, alongside licensure claims across all 50 states and a sizable increase in the provider network. Ongoing job postings and visible senior roles support an expanding operational footprint.
Product Line Growth:
Company communications note a move beyond weight loss into broader metabolic health and additional categories such as mental health, hormones, hair loss, and dermatology. New insurance‑based offerings are framed as part of scaling access.
